Pharmacogenetic Analysis of TPMT and NUDT15 in a European Pediatric Cohort with IBD and Autoimmune Diseases: Frequency Data and Clinical Relevance

Background/Objectives: Thiopurines remain a cornerstone in the management of inflammatory bowel disease (IBD) and gastrointestinal immune diseases but are associated with significant interindividual variability in efficacy and toxicity, mainly influenced by polymorphisms in Thiopurine S-methyltransferase TPMT and Nudix Hydrolase 15 NUDT15. This study aimed to assess the frequency of TPMT and NUDT15 variants in a pediatric cohort and evaluate their clinical impact to support a pharmacogenetic-guided approach to thiopurine therapy. Methods: Eighty-three pediatric patients with IBD and other autoimmune diseases were genotyped for clinically relevant TPMT and NUDT15 variants using two HRM-PCR assays and were confirmed with sequencing. Variant frequencies were compared to expected population data, and clinical records were reviewed to assess thiopurine dosing, tolerance, and adverse events. Results: Among the cohort, six carried heterozygous TPMT variants *1/*3A, while 2 carried the NUDT15 *1/*9 diplotype, with frequencies higher than expected. Among patients with TPMT variant alleles, some needed dose reductions or treatment discontinuation due to adverse effects, while others tolerated standard dosing without significant issues. Notably, no significant differences in adverse reactions were observed between NUDT15 *1/*9 carriers and wild-type patients. Conclusions: Our results confirm the clinical relevance of TPMT and NUDT15 genotyping to personalize thiopurine therapy in pediatric IBD. Routine implementation of rapid genetic testing, combined with therapeutic drug monitoring and a structured management algorithm, may optimize treatment outcomes and minimize preventable toxicity.

• Publication year

  2025

• Venue

  Genes

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/genes16111372PMID 41300822PMCID 12652446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug–Gene Pairs to Know

  2023cited by this paper
• Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases

  2021cited by this paper
• Importance of NUDT15 Polymorphisms in Thiopurine Treatments

  2021cited by this paper
• Reducing risk in thiopurine therapy

  2020influential reference
• Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

  2019influential reference
• Combined evaluation of genotype and phenotype of thiopurine S-methyltransferase (TPMT) in the clinical management of patients in chronic therapy with azathioprine

  2019influential reference
• British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

  2019cited by this paper
• Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.

  2017cited by this paper
• Treating children with inflammatory bowel disease: Current and new perspectives

  2017cited by this paper
• NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity

  2016influential reference
• Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease

  2016cited by this paper
• Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study

  2016influential reference
• Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.

  2015cited by this paper
• Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.

  2015cited by this paper
• EASL Clinical Practice Guidelines: Autoimmune hepatitis.

  2015cited by this paper
• The Role of Thiopurines in Reducing the Need for Surgical Resection in Crohn's Disease: A Systematic Review and Meta-Analysis

  2014cited by this paper
• A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia

  2014influential reference
• A New Thiopurine S‐Methyltransferase Haplotype Associated With Intolerance to Azathioprine

  2013cited by this paper
• Human MTH3 (NUDT18) Protein Hydrolyzes Oxidized Forms of Guanosine and Deoxyguanosine Diphosphates

  2012cited by this paper
• Adverse reactions to azathioprine cannot be predicted by thiopurine S‐methyltransferase genotype in Japanese patients with inflammatory bowel disease

  2009cited by this paper
• Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.

  2007cited by this paper
• Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions

  2006cited by this paper
• Review article: thiopurines in inflammatory bowel disease

  2006cited by this paper
• European Association for the Study of the Liver

  2006cited by this paper
• Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine

  2005influential reference
• Real-time PCR in the microbiology laboratory.

  2004cited by this paper
• Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

  2000influential reference
• A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease.

  2000cited by this paper
• Pharmacokinetics, dose adjustments, and 6‐mercaptopurine/ methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency

  1998cited by this paper
• Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance

  1997cited by this paper
• A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.

  1995cited by this paper

• No citing papers are available for this paper.